Todos Medical Retains CRO for COVID-19 Outpatient and Inpatient Phase 2/3 Clinical Trials for Oral Antiviral 3CL Protease Inhibitor Tollovir
Trials will separately enroll non-hospitalized and hospitalized patientsClinical trials in India targeted to be adaptive design to enable expansion into...